|
2024
|
Invention
|
Immunogenic compounds for cancer therapy.
The invention relates to an immunogenic compound compr... |
|
2023
|
Invention
|
Antigenic peptides for prevention and treatment of b-cell malignancy.
The present invention rela... |
|
|
Invention
|
Microbiota sequence variants of tumor-related antigenic epitopes. The present invention relates t... |
|
|
Invention
|
Antigenic peptides for prevention and treatment of cancer.
The present invention relates to anti... |
|
|
Invention
|
Antigenic peptides for prevention and treatment of cancer. The present invention relates to antig... |
|
2022
|
Invention
|
Process for preparing mannose derivatives.
The invention relates to a process to prepare a compo... |
|
|
Invention
|
Immunogenic compounds for cancer therapy. The invention relates to an immunogenic compound compri... |
|
|
Invention
|
Il-10 inducing polypeptides and uses thereof.
The present invention relates to polypeptides, whi... |
|
|
Invention
|
Il-10 inducing polypeptides and uses thereof. The present invention relates to polypeptides, whic... |
|
|
Invention
|
Antigenic peptides for treatment of b-cell malignancy. The present invention relates to antigen-b... |
|
2021
|
Invention
|
Use of adlercreutzia bacteria for the treatment of inflammatory diseases.
The present invention ... |
|
|
Invention
|
Compositions for treating epithelial barrier function disorders.
The present disclosure relates ... |
|
|
Invention
|
Identification and synthesis of drug candidates derived from human microbiome metasecretome prote... |
|
|
Invention
|
Microbiota-derived proteins inducing il-10 release from human cells and uses thereof.
The presen... |
|
|
Invention
|
Compositions for treating epithelial barrier function disorders. The present disclosure relates t... |
|
|
Invention
|
Micribiota-derived proteins inducing il-10 release from human cells and uses thereof. The present... |
|
2020
|
Invention
|
Antigenic peptides for prevention and treatment of b-cell malignancy. The present invention relat... |
|
|
Invention
|
Immunogenic compounds for treatment of adrenal cancer.
The present invention relates to antigen-... |
|
|
Invention
|
Immunogenic compounds for treatment of adrenal cancer. The present invention relates to antigen-b... |
|
2019
|
Invention
|
Process for preparing mannose derivatives. 6)alkyl, R represents a hydrogen atom or a protective ... |
|
|
Invention
|
Process for preparing mannose derivatives. The invention relates to a process to prepare a compou... |
|
|
Invention
|
Immunogenic compounds for treatment of fibrosis, autoimmune diseases and inflammation.
The prese... |
|
|
Invention
|
Immunogenic compounds for treatment of fibrosis, autoimmune diseases and inflammation. The presen... |
|
2018
|
Invention
|
Tools for assessing fimh blockers therapeutic efficiency. The present invention relates to an in ... |
|
|
Invention
|
New tools for assessing fimh blockers therapeutic efficiency. in vitrofimfimH gene in a stool sam... |
|
|
Invention
|
Microbiota sequence variants of tumor-related antigenic epitopes.
The present invention relates ... |
|
|
Invention
|
Gene signatures of inflammatory disorders that relate to the liver. This invention is related to ... |
|
|
Invention
|
Host dna as a biomarker of crohn's disease. The invention relates to methods of analysing a sampl... |
|
2016
|
Invention
|
Mannose derivatives useful for treating pathologies associated with adherent e. coli. The present... |
|
|
Invention
|
Host dna as a biomarker of crohn's disease. The invention relates to methods of analyzing a sampl... |
|
|
Invention
|
Host dna as a biomarker of crohn's disease. The present invention relates to an in vitro method f... |
|
2013
|
P/S
|
Human pharmaceutical research; research services provided by a pharmaceutical laboratory, namely,... |
|
|
P/S
|
Chemical and biochemical substances used for the manufacture
and preservation of foodstuffs, of ... |
